510(k) Report

510(k) · Cleared

Recalled · 2007

Homogeneous Enzymic Homocysteine Reagent

K011692510(k) TraditionalCleared Jul 25, 200155-day reviewClass II21 CFR 862.1377Recalls 1

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Intersect Systems, Inc. · LPS Urinary Homocystine (Nonquantitative) Test System

Cleared on Jul 25, 2001 after a 55-day review. FDA’s file for it is a 510(k) statement, which names no predicate. It has been recalled once.

Decided
Jul 25, 2001
Review
55 days
Class
Class II
Product code
LPS
Recalls
1
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K011692Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LPS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jan 18, 2007Not classifiedZ-0448-2009Device DesignA high homocysteine level can be reported as falsely low.

No ancestor or descendant has a Class I recall.

How does its category compare?

All LPS devices

LPS Urinary Homocystine (Nonquantitative) Test System: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LPS

1in 2013

2007: 22008: 22009: 12012: 42013: 1
2007high 4 (2012) · low 0 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LPS

141in 2012

2012: 141 days median
2007high 141 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LPS

1in 2024

2007: 12011: 12012: 12013: 12018: 12019: 42024: 1
2007high 4 (2019) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LPS

1in 2024

2014: 12015: 22016: 12017: 82021: 12024: 1
2007high 8 (2017) · low 0 (2007)2025

MAUDE reports naming product code LPS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—10
20082—00
20091—00
20100—00
20110—10
2012414110
20131—10
20140—01
20150—02
20160—01
20170—08
20180—10
20190—40
20200—00
20210—01
20220—00
20230—00
20240—11
20250—00
20260—0—

What is it indicated for?

A homocysteine test system is an in vitro device intended to measure total homocysteine quantitatively in serum or plasma. Homocysteine measurements are used in the diagnosis and treatment of hyperhomocysteinemia.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K011692: Homogeneous Enzymic Homocysteine Reagent.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K011692

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Page last updated Nov 3, 2026